Tung Gurra*
Lung diseases continue to pose significant challenges to global healthcare systems, with conditions such as asthma, Chronic Obstructive Pulmonary Disease (COPD) and lung cancer affecting millions of individuals worldwide. Traditional treatments have focused on symptom management and disease control, but recent advances in immunotherapy have opened up new possibilities for the treatment of lung diseases. This article explores the current trends and future directions of immunotherapy in managing lung diseases, shedding light on the potential for improved outcomes and better quality of life for patients.
この記事をシェアする
English 
Spanish 
Chinese 
Russian 
German 
French 
Portuguese 
Hindi 